Hillstream Biopharma Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Hillstream Biopharma regular Real Value cannot be determined due to lack of data. The prevalent price of Hillstream Biopharma is $0.0. Our model calculates the value of Hillstream Biopharma from evaluating the firm fundamentals such as Return On Asset of -0.78, return on equity of -1.47, and Shares Owned By Insiders of 38.90 % as well as inspecting its technical indicators and probability of bankruptcy.
Hillstream Biopharma Total Value Analysis
Hillstream Biopharma is currently expected to have valuation of 496.66 K with market capitalization of 4.23 M, debt of 772.9 K, and cash on hands of 9.48 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Hillstream Biopharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
496.66 K | 4.23 M | 772.9 K | 9.48 M |
Hillstream Biopharma Asset Utilization
One of the ways to look at asset utilization of Hillstream is to check how much profit was generated for every dollar of assets it reports. Hillstream Biopharma retains a negative application of resources of -0.78 (percent), losing $0.007797 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Hillstream Biopharma shows how discouraging it operates for each dollar spent on its resources.Hillstream Biopharma Ownership Allocation
Hillstream Biopharma has a total of 17.53 Million outstanding shares. Hillstream Biopharma secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Hillstream Biopharma Profitability Analysis
Net Loss for the year was (8.47 M) with profit before overhead, payroll, taxes, and interest of 0.Hillstream Biopharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Hillstream Biopharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 11.2 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |